ORAL COMPOSITION FOR ALLEVIATING ULTRAVIOLET IRRADIATION-INDUCED DAMAGE
    4.
    发明申请
    ORAL COMPOSITION FOR ALLEVIATING ULTRAVIOLET IRRADIATION-INDUCED DAMAGE 审中-公开
    用于治疗超紫外线辐射诱导性损伤的口腔组合物

    公开(公告)号:US20120189563A1

    公开(公告)日:2012-07-26

    申请号:US13261161

    申请日:2010-03-31

    摘要: Disclosed are: an oral composition for alleviating ultraviolet irradiation-induced damage, which can be used on a daily basis and is stable and safe; and a medicinal agent; and anti-wrinkle agent and a food composition, each of which comprises the oral composition. Specifically disclosed is an oral composition for alleviating ultraviolet irradiation-induced damage, which comprises at least one compound selected from the group consisting of methionine and derivatives and/or salts thereof. The composition may be an anti-wrinkle agent, a pharmaceutical composition for treating and/or preventing skin diseases, a food composition, or a pharmaceutical composition for preventing or treating cataract. In the oral composition for alleviating ultraviolet irradiation-induced damage, methionine may be in the D-form.

    摘要翻译: 公开了一种用于减轻紫外线照射引起的损伤的口服组合物,其可以每天使用并且是稳定和安全的; 和药剂; 和抗皱剂和食品组合物,其各自包含口腔组合物。 具体公开了一种用于减轻紫外线照射诱发的损伤的口服组合物,其包含至少一种选自甲硫氨酸及其衍生物和/或盐的化合物。 组合物可以是抗皱剂,用于治疗和/或预防皮肤病的药物组合物,食品组合物或用于预防或治疗白内障的药物组合物。 在用于减轻紫外线照射诱发的损伤的口服组合物中,甲硫氨酸可以是D-型。